thiophenes has been researched along with Blood Pressure, High in 258 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 59 (22.87) | 18.7374 |
| 1990's | 36 (13.95) | 18.2507 |
| 2000's | 102 (39.53) | 29.6817 |
| 2010's | 55 (21.32) | 24.3611 |
| 2020's | 6 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Majer, J; Masajtis-Zagajewska, A; Nowicki, M | 1 |
| Carletti, R; Castoldi, G; di Gioia, CRT; Ippolito, S; Pelucchi, S; Stella, A; Zatti, G; Zerbini, G | 1 |
| Chiong, M; Hernandez-Fuentes, C; Lavandero, S; Lopez-Crisosto, C; Martinez-Bilbao, J; Norambuena-Soto, I; Parra, V | 1 |
| Baelde, HJ; Danser, AHJ; de Vries, R; Garrelds, IM; Mirabito Colafella, KM; Montezano, AC; Neves, KB; Touyz, RM; Uijl, E; van den Meiracker, AH; van Veghel, R; Versmissen, J | 1 |
| Bader, M; de Kloet, AD; Elsaafien, K; Frazier, CJ; Harden, SW; Johnson, DN; Krause, EG; Mohammed, M; Scott, KA; Sheng, W; Spector, EA; Steckelings, UM; Sumners, C; Wang, LA | 1 |
| Anitha, P; Babu, D; Gayathri, R; Mohan, S; Ramkanth, S | 1 |
| Kajiya, S; Kawasoe, M; Kawasoe, S; Kubozono, T; Maruguchi, Y; Miyata, M; Ohishi, M; Uenomachi, H | 1 |
| Fushimi, Y; Hirukawa, H; Kaku, K; Kamei, S; Kaneto, H; Kimura, T; Kinoshita, T; Kohara, K; Mune, T; Nakanishi, S; Nishioka, M; Obata, A; Okauchi, S; Sanada, J; Shimoda, M; Tatsumi, F | 1 |
| Ahmed, HA; Arbab, AS; Bunting, KM; Ergul, A; Fagan, SC; Ishrat, T; Patel, A; Pillai, B; Vazdarjanova, A; Waller, JL | 1 |
| Tahara, A; Takasu, T | 1 |
| Dopona, EPB; Furukawa, LNS; Heimann, JC; Oliveira, IB; Rocha, VF | 1 |
| Catalá-López, F; de la Fuente Honrubia, C; Macías Saint-Gerons, D; Montero Corominas, D | 1 |
| Ahmad, Y; Lip, GY | 1 |
| Ackaert, O; Koopmans, RP; Mathôt, RA; Ploeger, BA; Snelder, N; van Hest, RM; van Rijn-Bikker, PC | 1 |
| Hanon, O; Lee, YS; Pathak, A | 1 |
| Diener, HC | 1 |
| Campagna, O; Colica, C; Cruciani, F; De Vico, U; Gharbiya, M | 1 |
| Goto, S; Hori, M; Iekushi, K; Izumi, T; Kajikawa, M; Kato, M; Koretsune, Y; Matsumoto, M; Momomura, S; Tajiri, M; Tanahashi, N; Uchiyama, S; Ueda, H; Yamanaka, S | 1 |
| De Backer, G; Gill, DP; Petrella, RJ; Tremblay, G | 1 |
| Abdo, S; Chan, JS; Chenier, I; Filep, JG; Ghosh, A; Ingelfinger, JR; Lo, CS; Otoukesh, A; Shi, Y; Zhang, SL | 1 |
| Chen, H; Higashino, H; Jin, D; Li, W; Miyazaki, M; Okamura, H; Takai, S; Yamamoto, H; Yamanishi, H; Yamanishi, K | 1 |
| Farrell, K; Heise, T; Natarajan, J; Plum-Mörschel, L; Polidori, D; Rothenberg, P; Sha, S; Sica, D; Wang, SS | 1 |
| Berthold, C; Boecher-Schwarz, H; Dooms, G; Gunness, VR; Hana, A; Hertel, F; Koy, J; Matgé, G; Standhardt, H | 1 |
| Bakris, G; Davies, M; de Zeeuw, D; Kline, I; Mayer, C; Meininger, G; Perkovic, V; Usiskin, K; Vijapurkar, U; Woo, V; Yamout, H | 1 |
| Guo, X; Li, L; Tang, B; Xu, G; Zhang, Y; Zhou, X | 1 |
| Fung, A; Gilbert, RE; Januszewicz, A; Kline, I; Meininger, G; Vijapurkar, U; Weir, MR | 1 |
| Brouwers, S; Dupont, AG; Smolders, I; Wainford, RD | 1 |
| Bakris, GL; Majewski, C | 1 |
| Hehemann, K; Maier, H; Vieth, M | 1 |
| Cogolludo, Á; Duarte, J; Gálvez, J; Gómez-Guzmán, M; Hermenegildo, C; Jiménez, R; Pérez-Vizcaíno, F; Romero, M; Toral, M; Utrilla, MP; Zarzuelo, MJ | 1 |
| Dai, SY; He, JJ; Peng, W; Shen, Y; Zhang, YP | 1 |
| Ah, YM; Choi, KH; Choi, YJ; Han, N; Kim, B; Kong, J; Lee, HY; Lee, JY; Oh, JM; Shin, WG; Yu, YM | 1 |
| Cheung, L; Cosgrove, D; Delimont, D; Dufek, B; Gratton, MA; Liu, S; Meehan, DT; Phillips, G; Song, W | 1 |
| Dessy, C; Duarte, J; Gómez-Gúzman, M; Jiménez, R; León-Gómez, E; Pérez-Vizcaíno, F; Rath, G; Rodríguez-Gómez, I; Romero, M; Sánchez, M; Tamargo, J; Toral, M; Zarzuelo, MJ | 1 |
| de Leeuw, PW; Houben, AJ; Kroon, AA; van Twist, DJ | 1 |
| Carey, RM; Gildea, JJ; Howell, NL; Keller, SR; Kemp, BA; Padia, SH | 1 |
| Claassen, JA; Heerschap, A; Kiliaan, AJ; Roelofs, M; van der Lugt, R; Wiesmann, M | 1 |
| Hallberg, A; Hallberg, M; Sävmarker, J | 1 |
| Ostroumova, OD; Pervichko, EI; Zinchenko, YP | 1 |
| Berrou, JP; Goch, JH; Hanon, O; Nádházi, Z; Negre-Pages, L; Pathak, A; Petrella, R; Sedefdjian, A; Sévenier, F; Shlyakhto, EV | 1 |
| Blankestijn, PJ; Rupp, H | 1 |
| Calderone, A; Gillis, MA; Gutkowska, J; Jankowski, M; Menaouar, A; Mukaddam-Daher, S; Paquette, PA; Shi, YF; Tardif, JC | 1 |
| Beltrán, B; Dasi, F; Gabriel, F; Guiral, V; Labiós, M; Martínez, M; Muñoz, A | 1 |
| Dowlatshahi, D; Hill, MD | 1 |
| Diener, HC; Gradl, B; Greiner, W; Jönsson, B; Lindgren, P; Lüders, S; Schrader, J; Schwander, B; Villar, FA; Zöllner, Y | 1 |
| Domínguez-Gil, A; Gregori, JA; Nuñez, JF | 1 |
| Enikeev, AKh; Kolomoets, NM; Zamotaev, IuN | 1 |
| Derosa, G; Ferrari, I; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Plosker, GL | 1 |
| Lai, CH | 1 |
| Antunes, F; Barreiro, EJ; Beiral, HJ; Fraga, CA; Kummerle, AE; Pereira, SL; Raimundo, JM; Sudo, RT; Zapata-Sudo, G | 1 |
| Hartog, JW; Jaarsma, W; Miyata, T; Plokker, HW; Schalkwijk, CG; Smit, AJ; van de Wal, RM; van Veldhuisen, DJ; van Wijk, LM; Voors, AA | 1 |
| Benndorf, RA; Böger, RH; Divac, N; Haefeli, WE; Herzog, M; Sauer, A; Schwedhelm, E; Weiss, J | 1 |
| Hartog, JW; Hummel, YM; Jaarsma, W; Plokker, TW; van de Wal, RM; van Veldhuisen, DJ; Vijn, RG; Voors, AA | 1 |
| Ambrosioni, E; Bombelli, M; Cerasola, G; Cipollone, F; Ferri, C; Grazioli, I; Leprotti, C; Mancia, G; Melzi, G; Mugellini, A; Mulè, G; Palasciano, G; Salvetti, A; Trimarco, B | 1 |
| Chang, CH; Chen, SJ; Chen, ST; Hsiao, YL; Shen, TW | 1 |
| Dhaun, N; Goddard, J; Haughie, S; Johnston, NR; Kerr, D; MacIntyre, IM; Melville, V; Webb, DJ | 1 |
| Dhaun, N; Goddard, J; Johnston, NR; Webb, DJ | 1 |
| Li, H; Shi, D; Shi, XY; Xu, FY; Yang, B; Zou, Z | 1 |
| Berrou, JP; Choueiry, P; Eid, E; Ismail, A; Pathak, A; Radaideh, GA; Sedefdjian, A; Sévenier, F | 1 |
| D'Urbano, M; De Servi, S; Navarese, EP; Savonitto, S | 1 |
| De Backer, G; Goudev, AR; Pathak, A; Petrella, RJ; Radaideh, GA; Rynkiewicz, A | 1 |
| Leibowitz, A; Paradis, P; Rautureau, Y; Rehman, A; Schiffrin, EL; Yamamoto, N | 1 |
| Baulmann, J; Becker, ST; Dahlöf, B; Kaschina, E; Lucht, K; Paulis, L; Schwengel, K; Slavic, S; Steckelings, UM; Thöne-Reineke, C; Unger, T | 1 |
| Berrou, JP; Konradi, AO; Pathak, A; Petrella, RJ; Sedefdjian, A; Shlyakhto, E | 1 |
| Zamotaev, IuN | 1 |
| Foulquier, S; Steckelings, UM; Unger, T | 1 |
| Berrou, JP; Goudev, A; Pathak, A | 1 |
| Biswas, P; Chaudhary, S; Hussain, ME; Karar, J; Kumar, K; Pasha, MA; Pasha, S; Seth, MK; Vats, ID | 1 |
| Mazur-Bialy, AI; Undas, A; Wypasek, E; Zdebska, K | 1 |
| Böhm, M; Sachse, A | 1 |
| Delles, C; Gekle, M; John, S; Schmieder, RE; Schneider, MP | 1 |
| Puig, JG; Ruilope, LM; Torres, R | 1 |
| Hedner, T | 2 |
| Gurevich, MA | 1 |
| Belavina, NI; Griabina, NA; Koren'kov, VV; Markova, LI; Radzevich, AE; Zharova, OIu | 1 |
| Nebieridze, DV; Oganov, RG | 1 |
| Jäger, B; Ruilope, L | 1 |
| Mancini, GB | 1 |
| Barin, ES; Gilfillan, KL; Stokes, GS | 1 |
| Frank, H; Heusser, K; Schmieder, RE; Schobel, HP; Vitkowsky, J | 1 |
| Schieffer, B; Schmidt, B | 1 |
| Terra, SG | 1 |
| Banes, AK; Watts, SW | 1 |
| Bernaud, C; Chanard, J; Hurault de Ligny, B; Lavaud, S; Moulin, B; Toupance, O | 1 |
| Dominiak, P; Häuser, W | 1 |
| Boĭko, AN; Gusev, EI; Makarov, AN; Martynov, MIu; Petukhov, EB | 1 |
| Aisaka, K; Cho, H; Fujisawa, A; Hase, Y; Hayakawa, K; Isoshima, H; Murakami, K; Nakanishi, H; Niwa, M; Uchida, I; Wakitani, K; Watanabe, H | 1 |
| Dragon, DN; Talman, WT | 1 |
| Koren'kov, VV; Markova, LI; Radzevich, AE; Shakhova, NI | 1 |
| Metlitskaia, EV; Petrik, ES; Shalaev, SV; Shanaurina, NV; Teffenberg, DV; Volkova, SIu | 1 |
| Ivanova, NA; Preobrazhenskiĭ, DV; Sidorenko, BA; Soplevenko, AV; Stetsenko, TM | 1 |
| Punzi, CF; Punzi, HA | 1 |
| Anderson, K; Angermann, CE; Barone, FC; Behr, TM; Berova, M; Coatney, RW; Sackner-Bernstein, JD; Willette, RN | 1 |
| Alonso, FJ; Blanco, J; Gamero, MJ; Jiménez Pérez, JL; Masot, J; Matilla, C; Nieto, J; Robles, NR; Romero, F; Velasco, J | 1 |
| Chen, Y; Currie, RW; Ross, BM | 1 |
| Ciccarelli, L; Derosa, G; Fogari, R; Mugellini, A; Ragonesi, PD | 1 |
| Charng, MJ; Ding, PY; Leu, HB | 1 |
| Aznar, J; Gabriel, F; Guiral, V; Labiós, M; Martínez, M; Munoz, A | 1 |
| Hatzizacharias, A; Krespi, P; Makris, TK; Papadopoulos, DP; Stavroulakis, G; Tsoukala, C; Votteas, VE; Zilidis, A | 1 |
| Lapina, EIa; Makarova, SV; Praskurnichiĭ, EA; Samartsev, GA; Shevchenko, OP | 1 |
| Arcos, E; de la Sierra, A; Lopez, JS; Munoz, A; Relats, J | 2 |
| Campbell, DJ; Esler, MD; Krum, H | 1 |
| Alamo, C; López-Muñoz, F; Martín-Agueda, B; Robles, NR | 2 |
| Berger, J; Diener, HC; Dominiak, P; Hammersen, F; Kulschewski, A; Lüders, S; Plate, K; Schrader, J; Zidek, W | 1 |
| Basile, J; Bloch, MJ | 1 |
| Arosio, E; De Marchi, S; Lechi, A; Prior, M; Rigoni, A | 1 |
| Robins, GW; Scott, LJ | 1 |
| Campbell, DJ; Esler, M; Krum, H; Lambert, E; Windebank, E | 1 |
| Brown, MJ; Cockcroft, JR; Dhakam, Z; McEniery, CM; Wilkinson, IB | 1 |
| Ametov, AS; Demidova, TIu; Kosykh, SA | 1 |
| Feldman, RD | 1 |
| Conter, HS; McKay, DW; Reiz, RJ | 1 |
| Chilvers, M; Reiz, RJ; Teitelbaum, I | 1 |
| Rubinstein, I | 1 |
| Frerichs, A; Frieg, R; Hahnheiser, D; Hammersen, F; Kulschewski, A; Lüders, S; Reich, G; Schnieders, M; Schrader, J; Schrandt, G | 1 |
| At'kova, EO; Gutnikova, OV; Tsfasman, AZ | 1 |
| Benedict, NJ | 1 |
| de la Sierra, A | 1 |
| Hanon, O; Negre-Pages, L; Pathak, A; Sevenier, F | 1 |
| de Leeuw, PW; Dielis, AW; Hamulyák, K; Houben, AJ; Kroon, AA; Smid, M; Spronk, HM; Ten Cate, H | 1 |
| Aulakh, GK; Singh, M; Sodhi, RK | 1 |
| Ram, CV; Rudmann, MA | 1 |
| de la Sierra, A; Ram, CV | 1 |
| Shlyakhto, E | 1 |
| Rupp, H | 1 |
| Cuppen, E; Mokry, M | 1 |
| Beltrán, B; Gabriel, F; Guiral, V; Labiós, M; Martínez, M; Muñoz, A; Ruiz-Aja, S | 1 |
| Makarova, SV; Praskurnichiĭ, EA; Savel'eva, SA; Shevchenko, OP; Zhukova, VA | 1 |
| Kumova, TA; Medvedev, IN; Simonenko, VB | 1 |
| Cohen, Y; Denoroy, L; Heimburger, M; Renaud, B; Sassard, J; Wepierre, J | 1 |
| Baarsma, GS; Henkes, HE; Houtsmuller, AJ; Klompe, M; Tijssen, J; Vermeulen, JA; Zahn, KJ | 1 |
| Hamilton, BP; Hamilton, J; Kuzbida, G; Levinson, P; Mersey, JH; Pavlis, R | 1 |
| Gerlis, LS; Wright, N | 1 |
| Hansson, BG; Hökfelt, B | 1 |
| Campbell, BC; Elliott, HL; Hamilton, CA; Reid, JL | 1 |
| Belvisi, L; Caliari, S; Canevotti, R; Cirillo, R; Fici, F; Paleari, F; Poma, D; Renzetti, AR; Salimbeni, A; Subissi, A | 1 |
| Beaufils, M | 2 |
| Laher, MS | 1 |
| Amendt, K; Diehm, C; Jacobsen, O | 1 |
| Vivet, P | 1 |
| Brouard, R; Du Cailar, G; Mimran, A; Ribstein, J | 1 |
| Guillet, C | 1 |
| Addo, MF; Falotico, R; Giardino, E; Haertlein, BJ; Katz, LB; Loughney, D; McNally, JJ; Press, JB; Sanfilippo, PJ | 1 |
| Janssen, BJ; Oosting, J; Struyker-Boudier, HA; Tyssen, CM | 1 |
| Boike, SC; Ilson, BE; Jorkasky, DK; Martin, DE | 1 |
| Oparil, S | 1 |
| Fink, GD; Watts, SW | 1 |
| Chung, O; Csikós, T; Unger, T | 1 |
| Hedner, T; Himmelmann, A | 1 |
| Bottorff, MB; Tenero, DM | 1 |
| Gavras, H; Gavras, I | 2 |
| Diamond, JA; Gharavi, A; Henzlova, MJ; Machac, J; Phillips, RA; Roychoudhury, D; Travis, A | 1 |
| Argenziano, L; Trimarco, B | 1 |
| Levine, B | 2 |
| Gradman, AH; Gray, J; Maggiacomo, F; Punzi, H; White, WB | 1 |
| Elliott, WJ | 1 |
| Buño, A; Dal-Ré, R; Mateos, F; Ortega, R; Puig, JG; Rodriguez, F | 1 |
| Sega, R | 1 |
| Brooks, DP; Ruffolo, RR | 1 |
| Shusterman, NH | 1 |
| Brooks, DP; Ohlstein, EH; Ruffolo, RR | 1 |
| Grossman, E; Messerli, FH; Neutel, JM | 1 |
| Foster, RH; Plosker, GL | 1 |
| Brooks, DP; Contino, LC; Grygielko, E; Laping, NJ; Olson, BA; Wong, VY | 1 |
| Benkel, M; Maisch, B; Rupp, H | 1 |
| Chikhladze, NM | 1 |
| Barone, FC; Brooks, DP; Campbell, WG; Chandra, S; Coatney, RW; Contino, LC; Nelson, AH; Ohlstein, EH; Sarkar, SK; Willette, RN | 1 |
| Magometschnigg, D | 1 |
| Gavras, HP | 1 |
| Sica, DA | 1 |
| Hollenberg, NK | 1 |
| Breeze, E; Donoghue, MD; Fletcher, AE; Rake, EC | 1 |
| Breeze, E; Fletcher, AE; Rake, EC | 1 |
| Anwar, YA; Mansoor, GA; Sica, DA; White, WB | 1 |
| Jäger, B; Prichard, B; Ruilope, L | 1 |
| McInnes, GT | 1 |
| Jäger, B; Sachse, A; Verboom, CN | 1 |
| Khan, BV; Khan, QA; Lauten, WB; Navalkar, S; Parthasarathy, S; Rahman, ST | 1 |
| Watts, SW | 1 |
| Al'-Iazidi, MA; Barsukov, AV; Konev, AV; Kulikov, AN; Shustov, SB | 1 |
| Abrahamsen, CT; Barone, FC; Brooks, DP; Campbell, WG; Contino, LC; Edwards, RM; Grygielko, ET; Laping, NJ; Nelson, AH; Pullen, MA | 1 |
| Delles, C; Fleischmann, I; Jacobi, J; John, S; Schmieder, RE | 1 |
| Berezov, VP; Boĭko, AN; Gusev, EI; Martynov, MIu; Maskarov, AN; Petukhov, EB | 1 |
| Rapi, J | 1 |
| Beauchemin, M; Gougoux, A; Lemieux, G; Vinay, P | 1 |
| Bolli, P; Simpson, FO; Waal-Manning, HJ | 1 |
| Bulpitt, CJ; Havard, CW; Pearson, RM | 1 |
| Bauthier, J; Charlier, R; Richard, J | 1 |
| Freis, ED; Kyle, MC; Nemati, M | 1 |
| Chrysant, SG; de Carvalho, JG; Dunn, FG; Frohlich, ED | 1 |
| Gillies, AH; Morgan, TO | 1 |
| Barritt, DW; Heaton, S; Marshall, AJ; Roberts, CJ | 1 |
| Miller, SA; Vertes, V | 1 |
| Furrer, J; Siegenthaler, W; Vetter, W | 1 |
| Bodison, W; Ellis, I; Fernandez, PC; Peitzman, SJ | 1 |
| Dupont, P; Lamy, F; Wauthier, P | 1 |
| Dollery, CT; Eckert, H; Hossmann, V; Zamboulis, C | 1 |
| Balant, L; Bruchez, B; Fabre, J; Salamin, L | 1 |
| Lelièvre, G; Lepoutre, E; Raviart, B; Tacquet, A | 1 |
| Borghetti, A; Borghi, L; Guariglia, A; Minari, M; Novarini, A; Peracchi, R | 1 |
| Bagli, JF; Ferdinandi, E; Mackay, WD | 1 |
| Bailey, RR | 1 |
| Axelrod, J; Grobecker, H; Saavedra, JM | 1 |
| Benfield, P; Chiu, AT; Herblin, WF; Smith, RD; Timmermans, PB; Wong, PC | 1 |
| Kliz, J; Tomaszewski, R | 1 |
| Brooks, DP; Edwards, RM; Fredrickson, TA; Gellai, M; Ruffolo, RR; Weinstock, J | 1 |
| Bui, F; Fallo, F; Folino, P; Gregianin, M; Macrì, C; Mantero, F | 1 |
| De Simone, G; Fasano, ML; Ferrara, LA; Gaeta, I; Iannuzzi, R | 1 |
| Brouard, R; Chaignon, M; Guédon, J; Lucsko, M | 1 |
| Betocchi, S; Condorelli, M; De Luca, N; Filardi, PP; Raponi, M; Ricciardelli, B; Rosiello, G; Trimarco, B | 1 |
| Smits, JF; Struyker-Boudier, HA | 1 |
| Condorelli, G; Condorelli, M; DeLuca, N; Marchegiano, R; Raponi, M; Ricciardelli, B; Rosiello, G; Trimarco, B | 1 |
| Carrageta, MD; Felix, S; Jobbé-Duval, M; Mota, JC; Nunes, AM | 1 |
| Guery, O; Herpin, D; Lecasble, M; Piron, J | 1 |
| Agnes, E; Prost, JF; Safar, ME; Vandermercken, C | 1 |
| Bajou, B; Herpin, D; Lecasble, M; Piron, J | 1 |
| Agnes, E; Laher, MS; Prost, JF | 1 |
| Bright, DA; Falotico, R; Keiser, JA; McNally, JJ; Press, JB; Rampulla, RA; Russell, RK; Tobia, A | 1 |
| Broersma, RJ; Huffman, JC; LeTourneau, ME; McCarthy, JR; Shea, PJ; Trepanier, DL; Whitten, JP; Wiech, NL; Wiedeman, PE; Zimmerman, MB | 1 |
| Brackman, F; Degaute, JP; Leeman, M; Naeije, R; Prost, JF | 1 |
| Jacotot, B; Martin, C; Richard, JL | 1 |
| Genevray, B; Grosgogeat, Y; Komajda, M | 1 |
| Nievelstein, HM; Smits, JF; Struyker-Boudier, HA; van Essen, H | 1 |
| Herman, AG; Verbeuren, TJ | 1 |
| Brackman, F; Degaute, JP; Leeman, M; Naeije, R; Prost, JF; Thomas, J | 1 |
| Ardaillou, R; Lantz, B; Leviel, F; Paillard, F | 1 |
| Bernini, GP; Di Stratis, P; Leonetti, G; Lucarini, AR; Mauro, M; Rupoli, L; Salvetti, A; Sangiorgio, P; Zanchetti, A | 1 |
| Beaufils, M; Lantz, B; Paillard, F; Richet, G | 1 |
| Desche, P; Prost, JF; Richard, C; Safar, ME | 1 |
| Gallet, M; Kleinknecht, D; Maurice, P | 1 |
| Condorelli, M; Cuocolo, A; de Luca, N; Lembo, G; Ricciardelli, B; Trimarco, B; Volpe, M | 1 |
| Brodsky, D; Gallet, M; Lestaevel, M; Lopez, M; Manchon, J | 1 |
| Jacotot, B; Richard, JL | 1 |
| Nadeau, JH; Primm, RK; Roden, DM | 1 |
| Abramowicz, M; Degaute, JP; Leeman, M; Naeije, R; Prost, JF; Schoutens, A | 1 |
| Campbell, DB; Chignon, JC; Devissaguet, JP | 1 |
| Kaiser, J; Lindner, E | 1 |
| Bauthier, J; Charlier, R; Delaunois, G | 1 |
46 review(s) available for thiophenes and Blood Pressure, High
| Article | Year |
|---|---|
Angiotensin-(1-9) in hypertension.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Hypertension; Imidazoles; Peptidyl-Dipeptidase A; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sulfonamides; Thiophenes | 2022 |
[Hepatotoxicity in patients treated with endothelin receptor antagonists: systematic review and meta-analysis of randomized clinical trials].
Topics: Antihypertensive Agents; Biomarkers; Bosentan; Chemical and Drug Induced Liver Injury; Endothelin Receptor Antagonists; Humans; Hypertension; Isoxazoles; Phenylpropionates; Pyridazines; Randomized Controlled Trials as Topic; Safety-Based Drug Withdrawals; Sulfonamides; Thiophenes; Transaminases | 2014 |
Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Comorbidity; Dabigatran; Disease Management; Embolism; Female; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Intracranial Embolism; Male; Morpholines; Patient Selection; Pyrazoles; Pyridones; Renal Insufficiency, Chronic; Risk; Risk Factors; Rivaroxaban; Severity of Illness Index; Stroke; Thiophenes; Thrombophilia; Warfarin | 2013 |
NOAC and intracerebral bleeding--presentation of four cases and review of the literature.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Female; Humans; Hypertension; Male; Morpholines; Rivaroxaban; Thiophenes | 2014 |
Angiotensin Peptides as AT2 Receptor Agonists.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Gene Expression; Humans; Hypertension; Inflammation; Kinetics; Peptides; Peptidomimetics; Receptor, Angiotensin, Type 2; Structure-Activity Relationship; Sulfonamides; Thiophenes | 2017 |
Clinical profile of eprosartan: a different angiotensin II receptor blocker.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Humans; Hypertension; Imidazoles; Kidney Diseases; Renin-Angiotensin System; Sympathetic Nervous System; Thiophenes | 2008 |
Eprosartan: a review of its use in hypertension.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Clinical Trials as Topic; Cough; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Incidence; Nitrendipine; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Recurrence; Risk Factors; Sodium Chloride Symporter Inhibitors; Thiophenes; Treatment Outcome | 2009 |
Antihypertensive effects and safety of eprosartan: a meta-analysis of randomized controlled trials.
Topics: Acrylates; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Randomized Controlled Trials as Topic; Thiophenes | 2012 |
Treating acute coronary syndromes with new antiplatelet drugs: the mortality issue with prasugrel and ticagrelor.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Coronary Angiography; Diabetes Mellitus; Female; Humans; Hypertension; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome | 2011 |
Impact of the AT(2) receptor agonist C21 on blood pressure and beyond.
Topics: Angiotensin Receptor Antagonists; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Hypertension; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sulfonamides; Thiophenes; Vasodilator Agents | 2012 |
Safety and tolerability of eprosartan in combination with hydrochlorothiazide.
Topics: Acrylates; Age Factors; Antihypertensive Agents; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Thiophenes | 2002 |
The clinical profile of the angiotensin II receptor blocker eprosartan.
Topics: Acrylates; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Drug Interactions; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Receptor, Angiotensin, Type 1; Thiophenes | 2002 |
[Policy of antihypertensive therapy in arterial hypertension in the elderly. II].
Topics: Acrylates; Adrenergic alpha-Antagonists; Age Factors; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Doxazosin; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Perindopril; Risk Factors; Sex Factors; Sodium Chloride Symporter Inhibitors; Thiophenes | 2002 |
Emerging role of angiotensin II type 1 receptor blockers for the treatment of endothelial dysfunction and vascular inflammation.
Topics: Acrylates; Aged; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Coronary Artery Disease; Data Interpretation, Statistical; Diabetes Mellitus; E-Selectin; Endothelium, Vascular; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Thiophenes; Vasculitis | 2002 |
Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Growth Hormone; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Models, Molecular; Receptor, Angiotensin, Type 1; Tetrazoles; Thiophenes; Thromboxane A2 | 2003 |
[Candesartan - a novel AT(1)-angiotensin receptor blocker: peculiarities of pharmacology and experience of use in arterial hypertension].
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Tetrazoles; Thiophenes; Valine; Valsartan | 2004 |
Eprosartan: a review of its use in the management of hypertension.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Clinical Trials as Topic; Humans; Hypertension; Imidazoles; Thiophenes | 2005 |
Sitaxsentan in the management of pulmonary arterial hypertension.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Drug Interactions; Humans; Hypertension; Isoxazoles; Thiophenes | 2007 |
Effects of eprosartan on target organ protection.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Endothelium, Vascular; Humans; Hypertension; Imidazoles; Neuroprotective Agents; Nitrendipine; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Research Design; Risk Factors; Stroke; Thiophenes; Treatment Outcome | 2006 |
An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Endothelin Receptor Antagonists; Humans; Hypertension; Imidazoles; Losartan; Protease Inhibitors; Receptors, Thromboxane A2, Prostaglandin H2; Renin; Renin-Angiotensin System; Thiophenes | 2007 |
Unique dual mechanism of action of eprosartan: effects on systolic blood pressure, pulse pressure, risk of stroke and cognitive decline.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Blood Pressure Determination; Cardiovascular Diseases; Cognition Disorders; Female; Humans; Hypertension; Imidazoles; Male; Sensitivity and Specificity; Severity of Illness Index; Stroke; Survival Analysis; Systole; Thiophenes; Treatment Outcome | 2007 |
Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10,000 patients and review of the literature.
Topics: Acrylates; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Animals; Cognition Disorders; Dementia, Vascular; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Neuropsychological Tests; Rats; Stroke; Thiophenes | 2007 |
Risk reduction by preventing stroke: need for blockade of angiotensin II and catecholamines?
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Catecholamines; Humans; Hypertension; Imidazoles; Norepinephrine; Stroke; Tetrazoles; Thiophenes; Valine; Valsartan | 2007 |
Preserving the autoregulation of renal hemodynamics.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Female; Homeostasis; Humans; Hypertension; Kidney Function Tests; Male; Propanolamines; Renal Circulation; Thiophenes | 1993 |
Overview of clinical safety and efficacy of tertatolol.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Hemodynamics; Humans; Hypertension; Middle Aged; Propanolamines; Risk Factors; Thiophenes; Time Factors | 1993 |
Overview of novel renal properties of tertatolol.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Humans; Hypertension; Kidney; Propanolamines; Renal Circulation; Renal Insufficiency; Thiophenes | 1993 |
Angiotensin II receptor pharmacology and AT1-receptor blockers.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Thiophenes | 1999 |
Pharmacokinetics of eprosartan in healthy subjects, patients with hypertension, and special populations.
Topics: Absorption; Acrylates; Age Factors; Antihypertensive Agents; Biological Availability; Clinical Trials, Phase III as Topic; Humans; Hypertension; Imidazoles; Sex Factors; Thiophenes | 1999 |
Safety and tolerability of eprosartan.
Topics: Acrylates; Antihypertensive Agents; Clinical Trials as Topic; Drug Tolerance; Humans; Hypertension; Imidazoles; Thiophenes | 1999 |
Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
Topics: Acrylates; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Imidazoles; Renin-Angiotensin System; Sympathetic Nervous System; Systole; Thiophenes; Treatment Outcome; Vascular Resistance | 1999 |
Management of hypertension: the advent of a new angiotensin II receptor antagonist.
Topics: Acrylates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Enalapril; Humans; Hypertension; Imidazoles; Survival Rate; Thiophenes; Treatment Outcome | 1999 |
Safety and efficacy of eprosartan, a new angiotensin II receptor blocker.
Topics: Acrylates; Angiotensin II; Antihypertensive Agents; Cardiovascular Diseases; Drug Interactions; Humans; Hypertension; Imidazoles; Thiophenes | 1999 |
Pharmacology of eprosartan, an angiotensin II receptor antagonist: exploring hypotheses from clinical data.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; Disease Models, Animal; Humans; Hypertension; Imidazoles; Rats; Receptors, Angiotensin; Renin-Angiotensin System; Sympathetic Nervous System; Thiophenes | 1999 |
Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors?
Topics: Acrylates; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Drug Therapy, Combination; Heart; Humans; Hypertension; Imidazoles; Irbesartan; Kidney; Losartan; Renin-Angiotensin System; Telmisartan; Tetrazoles; Thiophenes | 2000 |
Eprosartan: a review of its use in the management of hypertension.
Topics: Acrylates; Antihypertensive Agents; Humans; Hypertension; Imidazoles; Thiophenes | 2000 |
Control of cardiomyocyte gene expression as drug target.
Topics: Acrylates; Amino Acid Sequence; Animals; Antihypertensive Agents; Calcium-Transporting ATPases; Catecholamines; Gene Expression Regulation; Heart Failure; Humans; Hypertension; Imidazoles; Molecular Sequence Data; Myocardium; Myosin Heavy Chains; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sequence Alignment; Sequence Homology, Amino Acid; Thiophenes | 2000 |
[Prospects for pharmacological effects on renin-angiotensin and sympathetic nervous systems in patients with arterial hypertension].
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Humans; Hypertension; Imidazoles; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sympathetic Nervous System; Thiophenes | 2000 |
[Angiotensin receptor blockers--significance for the therapy of hypertension].
Topics: Acrylates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Austria; Benzimidazoles; Benzoates; Biphenyl Compounds; Humans; Hypertension; Imidazoles; Losartan; Prodrugs; Telmisartan; Tetrazoles; Therapeutic Equivalency; Thiophenes; Valine; Valsartan | 2001 |
Issues in hypertension: drug tolerability and special populations.
Topics: Acrylates; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Interactions; Humans; Hypertension; Imidazoles; Middle Aged; Patient Compliance; Receptors, Angiotensin; Thiophenes; United States | 2001 |
Pharmacology and clinical efficacy of angiotensin receptor blockers.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Humans; Hypertension; Imidazoles; Renin-Angiotensin System; Sympathetic Nervous System; Thiophenes; Treatment Outcome | 2001 |
Potential of the angiotensin II receptor 1 blocker eprosartan in the management of patients with hypertension or heart failure.
Topics: Acrylates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Heart Failure; Humans; Hypertension; Imidazoles; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sympathetic Nervous System; Thiophenes; Treatment Outcome | 2001 |
Angiotensin II antagonists in systolic blood pressure control.
Topics: Acrylates; Angiotensin II; Antihypertensive Agents; Blood Pressure; Delivery of Health Care; Humans; Hypertension; Imidazoles; Renin-Angiotensin System; Systole; Thiophenes | 2001 |
[Irbesartan: a new possibility in the treatment of hypertension].
Topics: Acrylates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Biological Availability; Biphenyl Compounds; Controlled Clinical Trials as Topic; Drug Administration Schedule; Enalapril; Half-Life; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan | 2002 |
Angiotensin II receptors and functional correlates.
Topics: Acrylates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Humans; Hypertension; Imidazoles; Losartan; Pyridines; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Thiophenes | 1992 |
Alterations in renal hemodynamics during chronic and acute beta-blockade in humans.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Hypertension, Renovascular; Kidney; Propanolamines; Renal Circulation; Thiophenes | 1989 |
Biodisposition of tertatolol in man: a review.
Topics: Humans; Hypertension; Kinetics; Propanolamines; Thiophenes; Tissue Distribution | 1986 |
88 trial(s) available for thiophenes and Blood Pressure, High
| Article | Year |
|---|---|
Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome.
Topics: Acrylates; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Fructose; Humans; Hypertension; Imidazoles; Losartan; Metabolic Syndrome; Middle Aged; Thiophenes; Uric Acid | 2021 |
Pharmacokinetic-pharmacodynamic modeling of the antihypertensive effect of eprosartan in Black and White hypertensive patients.
Topics: Acrylates; Adult; Antihypertensive Agents; Black People; Blood Pressure; Cross-Over Studies; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Models, Biological; Thiophenes; White People | 2013 |
Rivaroxaban versus warfarin in Japanese patients with non-valvular atrial fibrillation in relation to hypertension: a subgroup analysis of the J-ROCKET AF trial.
Topics: Aged; Asian People; Atrial Fibrillation; Double-Blind Method; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Humans; Hypertension; Japan; Male; Morpholines; Rivaroxaban; Thiophenes; Treatment Outcome; Warfarin | 2014 |
Effect of the sodium glucose co-transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Canagliflozin; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fasting; Female; Glucosides; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Kidney; Male; Metformin; Middle Aged; Plasma Volume; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Treatment Outcome; Water-Electrolyte Balance; Weight Loss | 2014 |
Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study.
Topics: Acrylates; Aged; Antihypertensive Agents; Blood Pressure; Cognition; Cognition Disorders; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Middle Aged; Neuropsychological Tests; Thiophenes; Treatment Outcome | 2008 |
Superoxide dismutase and catalase anti-oxidant activity in leucocyte lysates from hypertensive patients: effects of eprosartan treatment.
Topics: Acrylates; Antihypertensive Agents; Antioxidants; Blood Pressure; Catalase; Cell Extracts; Female; Heart Rate; Humans; Hypertension; Imidazoles; Leukocytes; Male; Middle Aged; Superoxide Dismutase; Thiophenes | 2009 |
Costs of eprosartan versus diuretics for treatment of hypertension in a geriatric population: an observational, open-label, multicentre study.
Topics: Acrylates; Aged; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Costs and Cost Analysis; Diuretics; Female; Geriatrics; Humans; Hypertension; Imidazoles; Male; Thiophenes | 2009 |
Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients.
Topics: Acrylates; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Female; Humans; Hypertension; Imidazoles; Insulin; Male; Middle Aged; Overweight; Telmisartan; Thiophenes | 2009 |
Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction.
Topics: Acrylates; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Diastole; Female; Glycation End Products, Advanced; Humans; Hypertension; Imidazoles; Linear Models; Lysine; Male; Middle Aged; Multivariate Analysis; Netherlands; Skin; Statistics as Topic; Statistics, Nonparametric; Stroke Volume; Thiophenes; Ventricular Function, Left | 2010 |
Effects of eprosartan on diastolic function and neurohormones in patients with hypertension and diastolic dysfunction.
Topics: Acrylates; Aged; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Diastole; Echocardiography; Female; Heart; Humans; Hypertension; Imidazoles; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Peptide Fragments; Peptidyl-Dipeptidase A; Stroke Volume; Thiophenes; Treatment Outcome; Ventricular Dysfunction; Ventricular Function; Ventricular Function, Left | 2010 |
Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
Topics: Acrylates; Aged; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Diuretics; Double-Blind Method; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Losartan; Male; Office Visits; Severity of Illness Index; Statistics, Nonparametric; Systole; Thiophenes; Treatment Outcome | 2010 |
Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease.
Topics: Adult; Antihypertensive Agents; Arteries; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Endothelin A Receptor Antagonists; Female; Glomerular Filtration Rate; Humans; Hypertension; Isoxazoles; Kidney Failure, Chronic; Male; Middle Aged; Nifedipine; Proteinuria; Radioimmunoassay; Thiophenes; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 2011 |
Chronic selective endothelin A receptor antagonism reduces serum uric acid in hypertensive chronic kidney disease.
Topics: Cross-Over Studies; Double-Blind Method; Endothelin A Receptor Antagonists; Hypertension; Hyperuricemia; Isoxazoles; Kidney Failure, Chronic; Thiophenes; Treatment Outcome; Uric Acid | 2011 |
Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study.
Topics: Acrylates; Aged; Analysis of Variance; Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Arabs; Blood Pressure; Chi-Square Distribution; Cognition; Female; Humans; Hypertension; Imidazoles; Logistic Models; Male; Middle Aged; Middle East; Psychiatric Status Rating Scales; Thiophenes; Time Factors; Treatment Outcome | 2011 |
Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension.
Topics: Acrylates; Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Enalapril; Endothelium, Vascular; Humans; Hypertension; Imidazoles; Male; Receptor, Angiotensin, Type 1; Thiophenes | 2002 |
AT1 blockers and uric acid metabolism: are there relevant differences?
Topics: Acrylates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Double-Blind Method; Humans; Hypertension; Imidazoles; Losartan; Receptor, Angiotensin, Type 1; Thiophenes; Uric Acid | 2002 |
[Metabolic effects of angiotensin-II receptor blockers].
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cholesterol; Endothelium, Vascular; Fibrin; Humans; Hypertension; Imidazoles; Male; Receptors, Angiotensin; Thiophenes | 2002 |
Effects of isosorbide mononitrate and AII inhibition on pulse wave reflection in hypertension.
Topics: Acrylates; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Imidazoles; Isosorbide Dinitrate; Male; Middle Aged; Pulse; Thiophenes; Time Factors; Vasodilator Agents | 2003 |
Effects of angiotensin II receptor antagonism on the renal hemodynamic response to cardiovascular stress.
Topics: Acrylates; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Blood Pressure; Cross-Over Studies; Double-Blind Method; Endocrine Glands; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Imidazoles; Lower Body Negative Pressure; Male; Renal Circulation; Severity of Illness Index; Thiophenes | 2003 |
Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients.
Topics: Adult; Amlodipine; Cyclosporine; Double-Blind Method; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hypertension; Hyperuricemia; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Propanolamines; Reference Values; Risk Assessment; Thiophenes; Transplantation Immunology; Treatment Outcome; Vasodilator Agents | 2003 |
[Antihypertensive treatment with eprosartan mesilate of patients in acute and late periods of ischemic stroke].
Topics: Acrylates; Acute Disease; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Chi-Square Distribution; Data Interpretation, Statistical; Diastole; Female; Hemodynamics; Humans; Hypertension; Imidazoles; Male; Middle Aged; Quality of Life; Recurrence; Stroke; Systole; Thiophenes; Time Factors | 2003 |
[Effect of eprosartan on microcirculation and blood rheology in patients with hypertensive disease].
Topics: Acrylates; Adult; Antihypertensive Agents; Female; Humans; Hypertension; Imidazoles; Male; Microcirculation; Middle Aged; Rheology; Thiophenes; Treatment Outcome | 2004 |
[Comparison of eprosartan and captopril in left ventricular systolic dysfunction: relation of efficacy to myocardial viability].
Topics: Acrylates; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Severity of Illness Index; Systole; Thiophenes; Ventricular Dysfunction, Left | 2004 |
Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
Topics: Acrylates; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Thiophenes; Treatment Outcome | 2004 |
Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Female; Glucose; Homeostasis; Humans; Hypertension; Imidazoles; Lipids; Male; Middle Aged; Telmisartan; Thiophenes | 2004 |
A double blind randomized trial to compare the effects of eprosartan and enalapril on blood pressure, platelets, and endothelium function in patients with essential hypertension.
Topics: Acrylates; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Enalapril; Endothelium, Vascular; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Platelet Activation; Prospective Studies; Thiophenes | 2004 |
Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation, and microparticle formation in hypertension.
Topics: Acrylates; Adult; Antihypertensive Agents; Blood Pressure; Calcium; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Particle Size; Platelet Activation; Prospective Studies; Stress, Mechanical; Thiophenes | 2004 |
Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
Topics: Acrylates; Aged; Angiotensin II Type 1 Receptor Blockers; Drug Administration Schedule; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Hemostasis; Humans; Hypertension; Imidazoles; Lipoproteins; Losartan; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 1; Thiophenes; Thrombomodulin; Time Factors; Tissue Plasminogen Activator | 2004 |
Losartan increases bradykinin levels in hypertensive humans.
Topics: Acrylates; Adolescent; Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Bradykinin; Chromatography, High Pressure Liquid; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydroxylation; Hypertension; Imidazoles; Kallidin; Losartan; Male; Middle Aged; Peptide Fragments; Radioimmunoassay; Thiophenes | 2005 |
Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients.
Topics: Acrylates; Adult; Aged; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Pulse; Thiophenes; Treatment Outcome | 2005 |
Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).
Topics: Acrylates; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Body Mass Index; Calcium; Cardiovascular Diseases; Female; Humans; Hypertension; Imidazoles; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nitrendipine; Prospective Studies; Recurrence; Risk Factors; Single-Blind Method; Sodium Chloride Symporter Inhibitors; Stroke; Thiophenes; Time Factors; Treatment Outcome | 2005 |
Haemodynamic effects of eprosartan and valsartan in hypertensive patients during isometric and mental stress.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Female; Forearm; Hand Strength; Heart Rate; Humans; Hypertension; Imidazoles; Laser-Doppler Flowmetry; Male; Microcirculation; Middle Aged; Skin; Stress, Psychological; Tetrazoles; Thiophenes; Time Factors; Treatment Outcome; Valine; Valsartan | 2005 |
Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension.
Topics: Acrylates; Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Cross-Over Studies; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Norepinephrine; Renin-Angiotensin System; Sympathetic Nervous System; Thiophenes | 2006 |
Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity.
Topics: Acrylates; Antihypertensive Agents; Aorta, Thoracic; Atenolol; Blood Pressure; Cross-Over Studies; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Pulsatile Flow; Receptor, Angiotensin, Type 1; Thiophenes; Treatment Outcome | 2006 |
Eprosartan mesylate effectively reduces systolic and diastolic blood pressure in a Canadian primary care setting.
Topics: Acrylates; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Blood Pressure Determination; Canada; Diastole; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Primary Health Care; Probability; Prospective Studies; Reference Values; Severity of Illness Index; Single-Blind Method; Systole; Thiophenes; Treatment Outcome | 2004 |
The angiotensin receptor blocker eprosartan mesylate reduces pulse pressure in isolated systolic hypertension.
Topics: Acrylates; Administration, Oral; Age Factors; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Blood Pressure Determination; Canada; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Middle Aged; Probability; Reference Values; Severity of Illness Index; Systole; Thiophenes; Treatment Outcome | 2004 |
[Effect of eprosartan on psychophysiological functions of drivers with arterial hypertension].
Topics: Acrylates; Adult; Angiotensin II Type 1 Receptor Blockers; Humans; Hypertension; Imidazoles; Male; Middle Aged; Occupational Diseases; Railroads; Thiophenes | 2006 |
Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10,000 patients and review of the literature.
Topics: Acrylates; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Animals; Cognition Disorders; Dementia, Vascular; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Neuropsychological Tests; Rats; Stroke; Thiophenes | 2007 |
Effects of eprosartan on mitochondrial membrane potential and H2O2 levels in leucocytes in hypertension.
Topics: Acrylates; Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Female; Humans; Hydrogen Peroxide; Hypertension; Imidazoles; Leukocytes; Male; Membrane Potential, Mitochondrial; Middle Aged; Oxidative Stress; Pilot Projects; Rhodamines; tert-Butylhydroperoxide; Thiophenes | 2008 |
[Effect of antihypertensive drugs of various pharmacological groups on reaction of arterial pressure under conditions of stree testing. Part II. Value of various strategies of potentiation of systemic vasodilatation].
Topics: Acrylates; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Exercise Test; Follow-Up Studies; Humans; Hypertension; Imidazoles; Lisinopril; Middle Aged; Propanolamines; Receptor, Angiotensin, Type 1; Thiophenes; Treatment Outcome; Vasodilation | 2008 |
The influence of ticlopidine on the natural course of retinal vein occlusion.
Topics: Adenosine Diphosphate; Adult; Aged; Anticoagulants; Clinical Trials as Topic; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Platelet Aggregation; Retinal Diseases; Retinal Vein; Risk; Thiophenes; Ticlopidine; Visual Acuity | 1984 |
Changes in blood pressure, plasma catecholamines and plasma renin activity during and after treatment with tiamenidine and clonidine.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Body Weight; Catecholamines; Clonidine; Epinephrine; Humans; Hypertension; Imidazoles; Male; Middle Aged; Norepinephrine; Renin; Thiophenes | 1981 |
Changes in blood pressure, heart rate, and sympathetic activity on abrupt withdrawal of tiamenidine (HOE 440) in essential hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Headache; Humans; Hypertension; Imidazoles; Male; Metanephrine; Middle Aged; Norepinephrine; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Thiophenes | 1980 |
European experience with artex: the Tertatolol International Multicentre Study (TIMS).
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Propanolamines; Thiophenes; Time Factors | 1993 |
The effects of tertatolol on lipid profile.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Dihydralazine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Intermittent Claudication; Lipids; Male; Metoprolol; Middle Aged; Propanolamines; Thiophenes; Time Factors | 1993 |
Overview of clinical safety and efficacy of tertatolol.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Hemodynamics; Humans; Hypertension; Middle Aged; Propanolamines; Risk Factors; Thiophenes; Time Factors | 1993 |
Comparative renal and cardiac effects of tertatolol and enalapril in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Echocardiography; Enalapril; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Function Tests; Male; Middle Aged; Propanolamines; Thiophenes; Time Factors | 1993 |
Overview of novel renal properties of tertatolol.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Humans; Hypertension; Kidney; Propanolamines; Renal Circulation; Renal Insufficiency; Thiophenes | 1993 |
The effects of eprosartan, an angiotensin II AT1 receptor antagonist, on uric acid excretion in patients with mild to moderate essential hypertension.
Topics: Acrylates; Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Creatinine; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Imidazoles; Male; Middle Aged; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Thiophenes; Uric Acid | 1998 |
The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group.
Topics: Acrylates; Aged; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Thiophenes; Treatment Outcome | 1999 |
Effect of long-term eprosartan versus enalapril antihypertensive therapy on left ventricular mass and coronary flow reserve in stage I-II hypertension. Eprosartan Study Group.
Topics: Acrylates; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Coronary Circulation; Double-Blind Method; Enalapril; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Thiophenes | 1999 |
Effect of eprosartan and enalapril in the treatment of elderly hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Topics: Acrylates; Age Factors; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Consumer Product Safety; Cough; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Imidazoles; Male; Thiophenes | 1999 |
Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Topics: Acrylates; Adult; Aged; Aged, 80 and over; Aldosterone; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Consumer Product Safety; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Renin; Thiophenes | 1999 |
Effect of eprosartan and enalapril in the treatment of black hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Topics: Acrylates; Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Blood Pressure; Consumer Product Safety; Cough; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Thiophenes | 1999 |
Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension. Eprosartan Study Group.
Topics: Acrylates; Age Factors; Aged; Angiotensin II; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Female; Heart Rate; Humans; Hypertension; Imidazoles; Male; Middle Aged; Placebos; Prospective Studies; Sex Factors; Thiophenes | 1999 |
Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients. Eprosartan Study Group.
Topics: Acrylates; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cough; Diuretics; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Incidence; Male; Middle Aged; Risk Factors; Single-Blind Method; Sodium Chloride Symporter Inhibitors; Surveys and Questionnaires; Thiophenes; Treatment Outcome | 1999 |
Effect of eprosartan and losartan on uric acid metabolism in patients with essential hypertension.
Topics: Acrylates; Administration, Oral; Aged; Antihypertensive Agents; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Thiophenes; Uric Acid | 1999 |
Efficacy and safety of eprosartan in severe hypertension. Eprosartan Multinational Study Group.
Topics: Acrylates; Administration, Oral; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Thiophenes | 1999 |
Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Topics: Acrylates; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Canada; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Severity of Illness Index; Sodium Chloride Symporter Inhibitors; Thiophenes; Treatment Outcome; United States | 2001 |
Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension.
Topics: Acrylates; Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cough; Double-Blind Method; Drug Administration Schedule; Enalapril; Europe; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Incidence; Male; Middle Aged; North America; Probability; Prospective Studies; Quality of Life; Risk Factors; Severity of Illness Index; South Africa; Thiophenes; Treatment Outcome | 2001 |
Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo.
Topics: Acrylates; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cough; Double-Blind Method; Drug Administration Schedule; Enalapril; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Incidence; Male; Middle Aged; Probability; Quality of Life; Reference Values; Risk Assessment; Severity of Illness Index; Thiophenes; Treatment Outcome | 2001 |
Evaluation of the 24-hour blood pressure effects of eprosartan in patients with systemic hypertension.
Topics: Acrylates; Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Thiophenes | 2001 |
Eprosartan versus enalapril in elderly patients with hypertension: a double-blind, randomized trial.
Topics: Acrylates; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Imidazoles; Male; Maximum Tolerated Dose; Therapeutic Equivalency; Thiophenes; Treatment Outcome | 2001 |
Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension.
Topics: Acrylates; Adult; Aged; Antihypertensive Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Thiophenes | 2002 |
Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
Topics: Acrylates; Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Vessels; Double-Blind Method; Drug Combinations; Enalapril; Enzyme Inhibitors; Hemodynamics; Humans; Hypertension; Imidazoles; Male; Nitric Oxide; omega-N-Methylarginine; Receptor, Angiotensin, Type 1; Renal Circulation; Thiophenes | 2002 |
Treatment of arterial hypertension with tienilic acid, a new diuretic with uricosuric properties.
Topics: Adult; Blood Pressure; Blood Urea Nitrogen; Calcium; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Evaluation; Electrocardiography; Electrolytes; Female; Glycolates; Humans; Hydrochlorothiazide; Hydrogen-Ion Concentration; Hypertension; Male; Middle Aged; Phenoxyacetates; Thiophenes; Uric Acid; Uricosuric Agents | 1978 |
Comparison of tienilic acid with cyclopenthiazide in hyperuricaemic hypertensive patients.
Topics: Blood Pressure; Body Weight; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Drug Evaluation; Electrolytes; Glucose Tolerance Test; Glycolates; Humans; Hypertension; Kidney; Kidney Function Tests; Phenoxyacetates; Pulse; Random Allocation; Sodium Chloride Symporter Inhibitors; Thiophenes; Uric Acid | 1978 |
Biochemical and haematological changes induced by tienilic acid combined with propranolol in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Blood Sedimentation; Clinical Trials as Topic; Creatinine; Diuretics; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Glycolates; Hemoglobins; Humans; Hypertension; Leukocyte Count; Male; Middle Aged; Phenoxyacetates; Potassium; Propranolol; Thiophenes; Urea; Uric Acid | 1979 |
Clinical study of ticrynafen. A new diuretic, antihypertensive, and uricosuric agent.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Body Weight; Clinical Trials as Topic; Diuretics; Drug Evaluation; Glycolates; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Phenoxyacetates; Thiophenes; Uric Acid; Uricosuric Agents | 1977 |
Ticrynafen: a novel uricosuric antihypertensive natriuretic agent.
Topics: Blood Pressure; Blood Urea Nitrogen; Blood Volume; Body Weight; Clinical Trials as Topic; Creatinine; Double-Blind Method; Glomerular Filtration Rate; Glycolates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Natriuresis; Phenoxyacetates; Potassium; Thiophenes; Uric Acid; Uricosuric Agents | 1978 |
A double-blind comparison of the effects of hydrochlorothiazide and tienylic acid (a diuretic with uricosuric properties) in hypertension.
Topics: Adult; Aged; Blood Pressure; Blood Urea Nitrogen; Body Weight; Carbon Dioxide; Chlorides; Clinical Trials as Topic; Creatinine; Diuretics; Double-Blind Method; Female; Glycolates; Humans; Hydrochlorothiazide; Hypertension; Liver Function Tests; Male; Middle Aged; Phenoxyacetates; Phosphates; Potassium; Sodium; Thiophenes; Uric Acid | 1978 |
Comparison of natriuretic, uricosuric, and antihypertensive properties of tienilic acid, bendrofluazide, and spironolactone.
Topics: Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Method; Glycolates; Humans; Hypertension; Natriuresis; Phenoxyacetates; Potassium; Spironolactone; Thiophenes; Uric Acid | 1979 |
Ticrynafen and hydrochlorothiazide. A double-blind study of antihypertensive properties with an open crossover.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Method; Female; Glycolates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Phenoxyacetates; Placebos; Thiophenes; Uric Acid | 1979 |
[Experiences with a new hypouricemic diuretic (tienilic acid): comparison with hydrochlorothiazide].
Topics: Adult; Clinical Trials as Topic; Diuretics; Female; Glycolates; Heart Arrest; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Phenoxyacetates; Systole; Thiophenes; Uric Acid | 1978 |
Comparative effects of ticrynafen and hydrochlorothiazide in the treatment of hypertension.
Topics: Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Method; Glycolates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Phenoxyacetates; Random Allocation; Thiophenes; Uric Acid; Uricosuric Agents | 1979 |
Ticrynafen and probenecid in hyperuricemic, hypertensive men.
Topics: Blood Pressure; Blood Urea Nitrogen; Clinical Trials as Topic; Creatinine; Diuresis; Double-Blind Method; Glycolates; Gout; Humans; Hypertension; Male; Middle Aged; Phenoxyacetates; Placebos; Probenecid; Thiophenes; Uric Acid; Uricosuric Agents | 1979 |
Double blind clinical study of tienilic acid and hydrochlorothiazide in primary arterial hypertension.
Topics: Adult; Aged; Blood Pressure; Diuretics; Double-Blind Method; Female; Glycolates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Phenoxyacetates; Posture; Thiophenes; Time Factors | 1979 |
Comparison of the antihypertensive and renal effects of tertatolol and nadolol in hypertensive patients with mild renal impairment.
Topics: Adrenergic beta-Antagonists; Double-Blind Method; Hemodynamics; Humans; Hypertension; Kidney; Nadolol; Propanolamines; Renal Circulation; Thiophenes | 1991 |
Cardiovascular response to adrenergic stimulation during treatment with tertatolol. A new non-cardioselective beta-blocking agent in primary hypertensive patients.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Myocardium; Oxygen Consumption; Propanolamines; Thiophenes | 1991 |
Antihypertensive effects of tertatolol. A comparative study versus atenolol.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atenolol; Female; Humans; Hypertension; Male; Middle Aged; Propanolamines; Thiophenes | 1989 |
Tertatolol in hypertension. Long-term therapy in 2,338 patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Propanolamines; Thiophenes; Time Factors | 1989 |
The Tertatolol International Multicenter Study (T.I.M.S.). Predicting factors of an efficient therapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Method; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Propanolamines; Random Allocation; Thiophenes | 1989 |
[Efficacy and tolerability of tertatolol in the treatment of mild to moderate arterial hypertension. Results of a French multicenter study with 2,338 patients treated over one year].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Female; France; Heart Rate; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Propanolamines; Thiophenes | 1989 |
Additional benefits of combining beta-blockade and renal vasodilation in the treatment of mild to moderate hypertension: Tertatolol International Multicentre Study results.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diuretics; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Multicenter Studies as Topic; Propanolamines; Randomized Controlled Trials as Topic; Thiophenes; Vasodilator Agents | 1989 |
Acute central and renal haemodynamic responses to tertatolol and propranolol in patients with arterial hypertension following head injury.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Cardiac Output; Craniocerebral Trauma; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Oxygen; Propanolamines; Propranolol; Pulmonary Wedge Pressure; Renal Circulation; Thiophenes | 1986 |
Antihypertensive effects of tertatolol: 3-month comparative study against acebutolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propanolamines; Thiophenes | 1986 |
[Comparative study of the effectiveness and acceptability of tertatolol 5 mg and acebutolol 400mg in the treatment of mild arterial hypertension].
Topics: Acebutolol; Administration, Oral; Adrenergic beta-Antagonists; Antihypertensive Agents; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Hypertension; Male; Propanolamines; Random Allocation; Thiophenes | 1987 |
Acute effects of tertatolol and nadolol on systemic and renal hemodynamics in patients with essential hypertension.
Topics: Adult; Cardiac Output; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nadolol; Propanolamines; Renal Circulation; Thiophenes; Vascular Resistance | 1988 |
127 other study(ies) available for thiophenes and Blood Pressure, High
| Article | Year |
|---|---|
Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension.
Topics: Angiotensin I; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Hypertension; Imidazoles; Injections, Intraperitoneal; Losartan; Male; Peptide Fragments; Proto-Oncogene Mas; Rats; Rats, Sprague-Dawley; Sulfonamides; Thiophenes; Tyrosine 3-Monooxygenase | 2021 |
Selective ETA vs. dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats.
Topics: Albuminuria; Animals; Antihypertensive Agents; Arteries; Blood Pressure; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Epoprostenol; Hypertension; Isoxazoles; Kidney; Male; Oxidative Stress; Pyrimidines; Rats, Inbred WKY; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; Sulfonamides; Sunitinib; Thiophenes | 2020 |
Targeting angiotensin type-2 receptors located on pressor neurons in the nucleus of the solitary tract to relieve hypertension in mice.
Topics: Animals; Hypertension; Imidazoles; Mice; Neurons; Receptor, Angiotensin, Type 2; Solitary Nucleus; Sulfonamides; Thiophenes | 2022 |
Formulation and design optimization of nano-transferosomes using pioglitazone and eprosartan mesylate for concomitant therapy against diabetes and hypertension.
Topics: Acrylates; Animals; Diabetes Mellitus, Type 2; Drug Carriers; Drug Delivery Systems; Humans; Hypertension; Imidazoles; Liposomes; Mesylates; Particle Size; Pioglitazone; Rats; Rats, Wistar; Thiophenes | 2021 |
Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes.
Topics: Adult; Antihypertensive Agents; Benzhydryl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypertension; Male; Middle Aged; Obesity; Plasma Volume; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2017 |
Switching from low-dose thiazide diuretics to sodium-glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension.
Topics: Aged; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Treatment Outcome | 2018 |
Role of angiotensin system modulation on progression of cognitive impairment and brain MRI changes in aged hypertensive animals - A randomized double- blind pre-clinical study.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Brain; Cognitive Dysfunction; Disease Progression; Double-Blind Method; Drug Evaluation, Preclinical; Hypertension; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Nootropic Agents; Organ Size; Random Allocation; Rats, Inbred SHR; Renin-Angiotensin System; Sulfonamides; Tetrazoles; Thiophenes | 2018 |
Prevention of progression of diabetic nephropathy by the SGLT2 inhibitor ipragliflozin in uninephrectomized type 2 diabetic mice.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucosides; Hypertension; Kidney; Losartan; Male; Mice, Inbred C57BL; Nephrectomy; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2018 |
Myocardial hypertrophy induced by high salt consumption is prevented by angiotensin II AT2 receptor agonist.
Topics: Animals; Blood Pressure; Cardiomegaly; Cardiovascular Agents; Disease Models, Animal; Fibrosis; Hypertension; Male; Myocytes, Cardiac; Rats, Wistar; Receptor, Angiotensin, Type 2; Signal Transduction; Sodium Chloride, Dietary; Sulfonamides; Thiophenes; Ventricular Remodeling; Weight Gain | 2019 |
Association between eprosartan-based hypertension therapy and improvement in cognitive function score: long-term follow-up from the OSCAR observational study.
Topics: Acrylates; Aged; Aged, 80 and over; Blood Pressure; Cognition; Demography; Diastole; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Middle Aged; Neuropsychological Tests; Systole; Thiophenes | 2015 |
Pro: "The novel oral anticoagulants should be used as 1st choice for secondary prevention in patients with atrial fibrillation.".
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Diabetes Complications; Female; Hemorrhage; Humans; Hypertension; Male; Middle Aged; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Secondary Prevention; Stroke; Thiophenes; Warfarin | 2013 |
Urrets- Zavalia Syndrome after glaucoma filtration device implantation.
Topics: Acetazolamide; Aged; Brimonidine Tartrate; Cataract Extraction; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Hypertension; Miotics; Mydriasis; Ocular Hypertension; Pilocarpine; Prostaglandins F; Quinoxalines; Sulfonamides; Syndrome; Thiophenes; Timolol | 2013 |
Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey.
Topics: Acrylates; Aged; Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Canada; Coronary Disease; Drug Therapy, Combination; Female; Health Care Surveys; Humans; Hypertension; Imidazoles; Male; Middle Aged; Primary Health Care; Risk Assessment; Risk Factors; Thiophenes; Time Factors; Treatment Outcome | 2014 |
DTB Select: 3 | March 2014.
Topics: Alzheimer Disease; Antibodies, Monoclonal, Murine-Derived; Automobile Driving; Child; Chronic Pain; Clopidogrel; Hepatitis B; Histamine H2 Antagonists; Humans; Hypertension; Practice Guidelines as Topic; Practice Patterns, Physicians'; Proton Pump Inhibitors; Respiratory Tract Infections; Rituximab; Thiophenes; Ticlopidine | 2014 |
Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice.
Topics: Acute Kidney Injury; Angiotensinogen; Animals; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Gene Expression; Hypertension; Kidney Tubules, Proximal; Mice; Mice, Transgenic; NF-E2-Related Factor 2; NF-kappa B; Pyrazines; Reverse Transcriptase Inhibitors; Signal Transduction; Thiones; Thiophenes | 2014 |
Chymase inhibition improves vascular dysfunction and survival in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Body Weight; Chymases; Endothelium, Vascular; Hypertension; Male; Matrix Metalloproteinase 9; Myocardium; Rats; Rats, Inbred SHR; Renin; RNA, Messenger; Stroke; Sulfonamides; Systole; Thiophenes | 2014 |
Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy.
Topics: Aged; Blood Glucose; Blood Pressure; Body Weight; Canagliflozin; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glucosides; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Severity of Illness Index; Thiophenes; Treatment Outcome | 2014 |
[The clinical analysis of atrial fibrillation of 1 310 in patients in Urumqi of China].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; China; Comorbidity; Diabetes Mellitus; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Humans; Hypertension; Incidence; Inpatients; Male; Morpholines; Retrospective Studies; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Warfarin | 2014 |
Effect of canagliflozin on blood pressure and adverse events related to osmotic diuresis and reduced intravascular volume in patients with type 2 diabetes mellitus.
Topics: Aged; Blood Pressure; Blood Pressure Determination; Canagliflozin; Diabetes Mellitus, Type 2; Diuresis; Female; Glucosides; Humans; Hypertension; Male; Middle Aged; Sodium-Glucose Transporter 2; Thiophenes | 2014 |
Hypotensive and sympathoinhibitory responses to selective central AT2 receptor stimulation in spontaneously hypertensive rats.
Topics: Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Consciousness; Enzyme Inhibitors; Hypertension; Imidazoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Norepinephrine; Pyridines; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; Species Specificity; Sulfonamides; Sympathetic Nervous System; Sympatholytics; Thiophenes | 2015 |
Blood pressure reduction: an added benefit of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes.
Topics: Benzhydryl Compounds; Blood Pressure; Canagliflozin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucosides; Humans; Hypertension; Hypoglycemic Agents; Middle Aged; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2015 |
Celiac disease-like enteropathy due to antihypertensive therapy with the angiotensin-II receptor type 1 inhibitor eprosartan.
Topics: Acrylates; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Celiac Disease; Female; Humans; Hypertension; Imidazoles; Thiophenes | 2015 |
Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity.
Topics: Adiponectin; Adipose Tissue; Animals; Aorta; Blood Glucose; Caveolin 1; Diet, High-Fat; Endothelium, Vascular; Glucose Tolerance Test; Hypertension; Insulin Resistance; Interleukin-6; Male; Mice; Nitric Oxide Synthase Type III; Obesity; PPAR delta; PPAR-beta; Reactive Oxygen Species; Sulfones; Thiazoles; Thiophenes; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Vasodilation | 2015 |
Central Infusion of Angiotensin II Type 2 Receptor Agonist Compound 21 Attenuates DOCA/NaCl-Induced Hypertension in Female Rats.
Topics: Animals; Blood Pressure; Cytokines; Desoxycorticosterone Acetate; Female; Heart Rate; Hypertension; Inflammation; Infusions, Intraventricular; Ovariectomy; Paraventricular Hypothalamic Nucleus; Rats, Wistar; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; RNA, Messenger; Sodium Chloride, Dietary; Sulfonamides; Thiophenes | 2016 |
Influence of initial angiotensin receptor blockers on treatment persistence in uncomplicated hypertension: A nation-wide population-based study.
Topics: Acrylates; Adult; Aged; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cohort Studies; Female; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Male; Medication Adherence; Middle Aged; Outcome Assessment, Health Care; Republic of Korea; Retrospective Studies; Risk Factors; Tetrazoles; Thiophenes; Valsartan | 2016 |
Endothelin A receptor activation on mesangial cells initiates Alport glomerular disease.
Topics: Animals; Biomechanical Phenomena; Disease Models, Animal; Endothelial Cells; Endothelin Receptor Antagonists; Endothelin-1; Fluorescent Antibody Technique; Gene Knockdown Techniques; Glomerular Basement Membrane; Hypertension; Isoxazoles; Laminin; Mesangial Cells; Mice; Mice, Inbred C57BL; Nephritis, Hereditary; Podocytes; Proteinuria; Pseudopodia; Receptor, Endothelin A; RNA Interference; RNA, Small Interfering; Signal Transduction; Thiophenes; Up-Regulation | 2016 |
Vascular and Central Activation of Peroxisome Proliferator-Activated Receptor-β Attenuates Angiotensin II-Induced Hypertension: Role of RGS-5.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Male; Mesenteric Arteries; Mice, Inbred C57BL; Norepinephrine; PPAR-beta; RGS Proteins; Sulfones; Thiazoles; Thiophenes; Vascular Resistance; Vasoconstriction | 2016 |
Acute eprosartan-induced intrarenal vasodilation in hypertensive humans is not influenced by dietary sodium intake or angiotensin II co-infusion.
Topics: Acrylates; Adult; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Essential Hypertension; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Receptor, Angiotensin, Type 1; Renal Artery; Renal Circulation; Renin-Angiotensin System; Sodium; Sodium, Dietary; Thiophenes; Vasodilation | 2016 |
AT2 Receptor Activation Prevents Sodium Retention and Reduces Blood Pressure in Angiotensin II-Dependent Hypertension.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Pressure; Female; Hypertension; Natriuresis; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Sodium; Sulfonamides; Thiophenes | 2016 |
Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Behavior, Animal; Blood Pressure; Brain; Cerebrovascular Circulation; Disease Models, Animal; Hypertension; Imidazoles; Maze Learning; Mice, Transgenic; Spatial Learning; Thiophenes | 2017 |
[Psychological Characteristics of Patients With Stress-induced Arterial Hypertension: a Violation of the Regulation of Emotions as a Central Link of Pathogenesis].
Topics: Acrylates; Adult; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Determination; Emotions; Female; Humans; Hypertension; Imidazoles; Indapamide; Male; Middle Aged; Random Allocation; Stress, Psychological; Thiophenes; Treatment Outcome | 2016 |
Hemodynamic and cardiac effects of chronic eprosartan and moxonidine therapy in stroke-prone spontaneously hypertensive rats.
Topics: Acrylates; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Heart Rate; Hypertension; Imidazoles; Male; Nitric Oxide Synthase Type III; Phosphorylation; Rats; Rats, Inbred SHR; Stroke; Thiophenes; Ventricular Function, Left | 2009 |
Angiotensin receptor blockers and secondary stroke prevention: the MOSES study.
Topics: Acrylates; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Female; Humans; Hypertension; Imidazoles; Ischemic Attack, Transient; Male; Nitrendipine; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thiophenes | 2009 |
Cost-utility analysis of eprosartan compared to enalapril in primary prevention and nitrendipine in secondary prevention in Europe--the HEALTH model.
Topics: Acrylates; Antihypertensive Agents; Cardiovascular Diseases; Cost-Benefit Analysis; Enalapril; Europe; Geography; Humans; Hypertension; Imidazoles; Male; Meta-Analysis as Topic; Middle Aged; Monte Carlo Method; Nitrendipine; Primary Prevention; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Risk Assessment; Secondary Prevention; Stroke; Thiophenes | 2009 |
[The use of melaxen in combined therapy of arterial hypertension in subjects occupied in assembly line production].
Topics: Acrylates; Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Central Nervous System Depressants; Circadian Rhythm; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypertension; Imidazoles; Industry; Melatonin; Middle Aged; Occupational Diseases; Occupational Exposure; Thiophenes; Treatment Outcome | 2009 |
Duloxetine related hypersexuality: a case report.
Topics: Adult; Duloxetine Hydrochloride; Humans; Hypertension; Male; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Stroke; Thiophenes | 2010 |
Pharmacological characterization of (3-thienylidene)-3,4-methylenedioxybenzoylhydrazide: a novel muscarinic agonist with antihypertensive profile.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Benzodioxoles; Blood Pressure; Cyclic GMP; Hypertension; In Vitro Techniques; Injections, Intravenous; Male; Muscarinic Agonists; Muscle Contraction; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Muscarinic; Thiophenes; Vasodilation | 2010 |
Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Benzimidazoles; Biological Transport; Biphenyl Compounds; Digoxin; Fluoresceins; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Membrane Transport Proteins; Mice; Multidrug Resistance-Associated Protein 2; Olmesartan Medoxomil; Tetrazoles; Thiophenes | 2010 |
Aripiprazole augmentation induced hypertension in major depressive disorder: a case report.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Drug Synergism; Duloxetine Hydrochloride; Female; Humans; Hypertension; Middle Aged; Piperazines; Quinolones; Thiophenes | 2011 |
Design and methodology of POWER, an open-label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertension.
Topics: Acrylates; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Canada; Cardiovascular Diseases; Humans; Hypertension; Imidazoles; Primary Health Care; Product Surveillance, Postmarketing; Research Design; Risk Factors; Thiophenes | 2013 |
Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Pressure; Collagen; Disease Models, Animal; Fibronectins; Fibrosis; Hypertension; Losartan; Macrophages; Male; Myocardium; Oxidative Stress; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 2; Stroke; Sulfonamides; Superoxides; Thiophenes; Vascular Stiffness | 2012 |
Direct angiotensin II type 2 receptor stimulation in Nω-nitro-L-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Flow Velocity; Blood Pressure; Body Weight; Collagen; Disease Models, Animal; Hydroxyproline; Hypertension; Imidazoles; Male; NG-Nitroarginine Methyl Ester; Olmesartan Medoxomil; Pulsatile Flow; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Sulfonamides; Tetrazoles; Thiophenes; Vascular Stiffness | 2012 |
Blood pressure responses to hypertension treatment and trends in cognitive function in patients with initially difficult-to-treat hypertension: a retrospective subgroup analysis of the Observational Study on Cognitive Function and SBP Reduction (OSCAR) st
Topics: Acrylates; Aged; Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Cognition; Female; Humans; Hypertension; Imidazoles; Intention to Treat Analysis; Male; Middle Aged; Retrospective Studies; Thiophenes | 2012 |
[The use of melatonin for correction of sleep disturbances in assembly-line shift workers with arterial hypertension].
Topics: Acrylates; Adult; Antihypertensive Agents; Circadian Clocks; Female; Humans; Hypertension; Imidazoles; Male; Melatonin; Middle Aged; Sleep Disorders, Circadian Rhythm; Thiophenes; Work Schedule Tolerance | 2012 |
Effect of eprosartan-based therapy on systolic blood pressure and total cardiovascular risk in a large international population: preliminary report of the observational POWER study.
Topics: Acrylates; Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 2 Receptor Blockers; Blood Pressure; Cardiovascular Diseases; Chi-Square Distribution; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Product Surveillance, Postmarketing; Risk Factors; Statistics, Nonparametric; Systole; Thiophenes; Treatment Outcome | 2012 |
Sulfur-containing angiotensin-converting enzyme inhibitor 3-thienylalanine-ornithyl-proline activates endothelial function and expression of genes involved in Renin-Angiotensin system.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Aorta; Captopril; Down-Regulation; Endothelium, Vascular; Free Radical Scavengers; Hypertension; Male; Nitric Oxide; Oligopeptides; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Wistar; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiophenes; Up-Regulation; Vasodilation | 2013 |
Repeated bleeding complications during therapy with vitamin K antagonists in a patient with the VKORC1*2A and the CYP2C9*3/*3 alleles: genetic testing to support switching to new oral anticoagulants.
Topics: Administration, Oral; Adult; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Exons; Female; Genetic Predisposition to Disease; Genetic Testing; Genotype; Haplotypes; Hemorrhage; Humans; Hypertension; Mixed Function Oxygenases; Morpholines; Mutation; Poland; Rivaroxaban; Thiophenes; Vitamin K; Vitamin K Epoxide Reductases; Warfarin | 2013 |
[Therapy of hypertension. Why the systolic value is decisive].
Topics: Acrylates; Antihypertensive Agents; Coronary Disease; Enalapril; Humans; Hypertension; Imidazoles; Risk Factors; Stroke; Systole; Thiophenes; Treatment Outcome | 2002 |
[Effect of eprosartan on left ventricular diastolic function and cerebral hemodynamics in patients with hypertension].
Topics: Acrylates; Adult; Antihypertensive Agents; Carotid Artery, Internal; Cerebrovascular Circulation; Diastole; Echocardiography; Female; Follow-Up Studies; Homeostasis; Humans; Hypertension; Imidazoles; Male; Middle Aged; Models, Cardiovascular; Thiophenes; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Ventricular Function, Left; Vertebral Artery | 2002 |
Eprosartan for the treatment of hypertension.
Topics: Acrylates; Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Female; Humans; Hypertension; Imidazoles; Male; Receptor, Angiotensin, Type 1; Spain; Thiophenes | 2003 |
Cardiology patient page. Angiotensin receptor blockers.
Topics: Acrylates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Diuretics; Dizziness; Drug Combinations; Drug Interactions; Heart Failure; Humans; Hypertension; Imidazoles; Irbesartan; Kidney Diseases; Losartan; Olmesartan Medoxomil; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan | 2003 |
Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension.
Topics: Animals; Arteries; Desoxycorticosterone; Female; Gene Expression; Hypertension; Indoles; Male; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2B; Serotonin Antagonists; Serotonin Receptor Agonists; Sodium Chloride; Thiophenes; Vasoconstriction | 2003 |
[When the goal values are more than 20/10 mmHg distant. High blood pressure is to be forced down from two sides immediately].
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzothiadiazines; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Sodium Chloride Symporter Inhibitors; Thiophenes; Time Factors | 2003 |
[Dosage equivalents of AT1-receptor antagonists available in Germany].
Topics: Acrylates; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Germany; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Olmesartan Medoxomil; Placebos; Telmisartan; Tetrazoles; Therapeutic Equivalency; Thiophenes; Time Factors; Valine; Valsartan | 2003 |
Synthesis and structure-activity relationships of 5,6,7,8-tetrahydro-4H-thieno[3,2-b]azepine derivatives: novel arginine vasopressin antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Binding, Competitive; Blood Platelets; CHO Cells; Cricetinae; Humans; Hypertension; In Vitro Techniques; Kidney; Liver; Male; Membranes; Models, Molecular; Radioligand Assay; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiophenes | 2004 |
Transmission of arterial baroreflex signals depends on neuronal nitric oxide synthase.
Topics: Amidines; Animals; Baroreflex; Blood Pressure; Enzyme Inhibitors; Glutamic Acid; Heart Rate; Hypertension; Injections; Male; Neurons; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitroprusside; Phenylephrine; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Reflex, Abnormal; Signal Transduction; Solitary Nucleus; Synaptic Transmission; Thiophenes | 2004 |
Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease.
Topics: Acrylates; Angiotensin II; Animals; Antihypertensive Agents; Chemokine CCL2; Down-Regulation; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Immunohistochemistry; Macrophages; Myocardial Contraction; Myocardium; Rats; Rats, Inbred SHR; RNA, Messenger; Thiophenes; Ultrasonography; Vasculitis | 2004 |
[Anti-hypertensive effect of eprosartan in diabetic patients].
Topics: Acrylates; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Diabetes Complications; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Thiophenes | 2004 |
Heat shock treatment protects against angiotensin II-induced hypertension and inflammation in aorta.
Topics: Acrylates; Angiotensin II; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Blotting, Western; Electrophoretic Mobility Shift Assay; Heat-Shock Response; Hot Temperature; HSP70 Heat-Shock Proteins; Hydralazine; Hypertension; Imidazoles; Inflammation; Interleukin-6; Intracellular Signaling Peptides and Proteins; Male; NF-kappa B; NF-kappa B p50 Subunit; Norepinephrine; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Thiophenes; Transcription Factor RelA | 2004 |
[Elevation pressure in morning hours in patients with essential hypertension: effect therapy with eprosartan for leading stress tests].
Topics: Acrylates; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Data Interpretation, Statistical; Exercise Test; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Thiophenes; Time Factors | 2004 |
Effect of eprosartan on pulse pressure and blood pressure components in patients with isolated systolic hypertension.
Topics: Acrylates; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Body Mass Index; Cardiovascular Diseases; Cholesterol, LDL; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Risk Factors; Sex Factors; Thiophenes; Time Factors | 2004 |
Analysis of recent papers in hypertension. An angiotensin receptor blocker is more effective than a calcium channel blocker in secondary stroke prevention.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Humans; Hypertension; Imidazoles; Nitrendipine; Randomized Controlled Trials as Topic; Stroke; Survival Rate; Thiophenes | 2005 |
[An AT-II blocker in patients with type II diabetes and arterial hypertension].
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Diastole; Female; Humans; Hypertension; Imidazoles; Insulin; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Receptor, Angiotensin, Type 1; Thiophenes; Time Factors; Treatment Outcome; Ventricular Function, Left | 2006 |
New tools, old challenges: the emerging role of angiotensin receptor blockers in the treatment of the systolic hypertension epidemic.
Topics: Acrylates; Age Factors; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Canada; Drug Utilization; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prognosis; Risk Assessment; Systole; Thiophenes; Treatment Outcome | 2004 |
The effect of treatment with eprosartan on pulse pressure: factors predicting response.
Topics: Acrylates; Administration, Oral; Aged; Aged, 80 and over; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Blood Pressure Determination; Canada; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Maximum Tolerated Dose; Middle Aged; Predictive Value of Tests; Probability; Prospective Studies; Risk Assessment; Severity of Illness Index; Thiophenes; Treatment Outcome | 2004 |
[Not all antihypertensive agents protect equally well].
Topics: Acrylates; Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Follow-Up Studies; Humans; Hypertension; Imidazoles; Meta-Analysis as Topic; Nitrendipine; Primary Prevention; Risk Factors; Stroke; Thiophenes; Time Factors | 2006 |
Prolonged anti-hypertensive effects of oral sitaxsentan, a selective ET(A) endothelin receptor antagonist, in spontaneoulsy hypertensive hamsters.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cricetinae; Endothelin A Receptor Antagonists; Hypertension; Isoxazoles; Male; Thiophenes | 2006 |
[Stress-associated hypertension in the work place: results of the STARLET project].
Topics: Acrylates; Adrenergic beta-Antagonists; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Middle Aged; Occupational Diseases; Prognosis; Prospective Studies; Stress, Physiological; Thiophenes; Workplace | 2006 |
Rationale, design and methods of the OSCAR study: observational study on cognitive function and systolic blood pressure reduction in hypertensive patients.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Cognition; Cognition Disorders; Female; Humans; Hypertension; Imidazoles; Longitudinal Studies; Male; Middle Aged; Multicenter Studies as Topic; Neuropsychological Tests; Observation; Patient Selection; Receptor, Angiotensin, Type 1; Research Design; Thiophenes | 2007 |
Changes in fibrinolytic activity after angiotensin II receptor blockade in therapy-resistant hypertensive patients.
Topics: Acrylates; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Blood Coagulation; Case-Control Studies; Drug Resistance; Endothelial Cells; Female; Fibrinolysis; Humans; Hypertension; Imidazoles; Male; Middle Aged; Thiophenes | 2007 |
Introduction: The pharmacological profile of eprosartan--implications for cerebrovascular and cardiovascular risk reduction.
Topics: Acrylates; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Cardiovascular Diseases; Cerebrovascular Disorders; Humans; Hypertension; Imidazoles; Middle Aged; Risk; Thiophenes | 2007 |
Effectiveness of eprosartan in diabetic hypertensive patients.
Topics: Acrylates; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Diabetes Complications; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Thiophenes; Time Factors; Treatment Outcome | 2008 |
The Atp1a1 gene from inbred Dahl salt sensitive rats does not contain the A1079T missense transversion.
Topics: Animals; DNA Mutational Analysis; Furans; Genotype; Hypertension; Mutation, Missense; Polymorphism, Genetic; Rats; Rats, Inbred Dahl; Sodium-Potassium-Exchanging ATPase; Species Specificity; Thiophenes | 2008 |
[Effect of eprosartan on thrombocytes aggregative capacity in patients with arterial hypertension and metabolic syndrome].
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Metabolic Syndrome; Middle Aged; Platelet Aggregation; Thiophenes; Treatment Outcome | 2008 |
Effects of chronic beta-blocker treatment on catecholamine levels in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Brain; Dopamine; Epinephrine; Heart Rate; Hypertension; Male; Norepinephrine; Organ Specificity; Propanolamines; Propranolol; Rats; Rats, Mutant Strains; Thiophenes | 1983 |
Withdrawal phenomena in subjects with essential hypertension on clonidine or tiamenidine.
Topics: Adult; Blood Pressure; Clonidine; Epinephrine; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Norepinephrine; Pulse; Random Allocation; Substance Withdrawal Syndrome; Thiophenes | 1984 |
Abrupt withdrawal of the antihypertensive agent tiamenidine after 12-months' treatment.
Topics: Antihypertensive Agents; Catecholamines; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Renin; Substance Withdrawal Syndrome; Thiophenes | 1980 |
N-3-substituted pyrimidinones as potent, orally active, AT1 selective angiotensin II receptor antagonists.
Topics: Administration, Oral; Angiotensin Receptor Antagonists; Animals; Humans; Hypertension; Male; Models, Molecular; Molecular Conformation; Molecular Structure; Pyrimidinones; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiophenes | 1995 |
Beta-Blockers in the Treatment of Hypertension in the 90's: Experience with Tertatolol. Conference proceedings. Istanbul, Turkey, October 19, 1993.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Humans; Hypertension; Propanolamines; Thiophenes | 1993 |
Novel thieno[2,3-b]- and [3,4-b]pyrans as potassium channel openers. Thiophene systems--XVII.
Topics: Animals; Antihypertensive Agents; Aorta; Benzopyrans; Cromakalim; Drug Evaluation, Preclinical; Glyburide; Hypertension; In Vitro Techniques; Models, Molecular; Molecular Structure; Potassium Channels; Pyrroles; Rats; Rats, Inbred SHR; Structure-Activity Relationship; Thiophenes | 1993 |
Time-dependent efficacy of antihypertensive agents in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Circadian Rhythm; Clonidine; Felodipine; Heart Rate; Hypertension; Labetalol; Male; Metoprolol; Oxazoles; Prazosin; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Rilmenidine; Thiophenes | 1993 |
The evolving role of angiotensin-II receptor blockers in cardiovascular risk reduction. Case study.
Topics: Acrylates; Adult; Antihypertensive Agents; Black People; Enalapril; Female; Humans; Hypertension; Imidazoles; Losartan; Receptors, Angiotensin; Thiophenes | 1998 |
5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Gastric Fundus; Gastrointestinal Motility; Hypertension; Indoles; Male; Mesenteric Arteries; Organic Chemicals; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sodium Chloride; Thiophenes; Time Factors; Vasoconstriction | 1999 |
A new ACE inhibitor and two new angiotensin receptor blockers for hypertension.
Topics: Acrylates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Clinical Trials as Topic; Contraindications; Double-Blind Method; Half-Life; Humans; Hypertension; Imidazoles; Perindopril; Telmisartan; Thiophenes | 1999 |
[Stroke prevention. Is there an added value to RAS inhibition?].
Topics: Acrylates; Animals; Antihypertensive Agents; Humans; Hypertension; Imidazoles; Randomized Controlled Trials as Topic; Rats; Stroke; Thiophenes | 2000 |
Gene expression in rats with renal disease treated with the angiotensin II receptor antagonist, eprosartan.
Topics: Acrylates; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Gene Expression Regulation; Hypertension; Imidazoles; Kidney Diseases; Male; Nephrectomy; Proteinuria; Rats; Rats, Sprague-Dawley; Thiophenes | 2000 |
[Stress-induced hypertension. The work site--a cardiovascular risk].
Topics: Acrylates; Antihypertensive Agents; Circadian Rhythm; Humans; Hypertension; Imidazoles; Occupational Diseases; Stress, Psychological; Thiophenes; Workplace | 2001 |
Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats.
Topics: Acrylates; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Cardiomegaly; Heart Rate; Hypertension; Imidazoles; Kidney; Magnetic Resonance Imaging; Male; Myocardium; Natriuresis; Organ Size; Peptide Fragments; Protein Precursors; Proteinuria; Rats; Rats, Inbred SHR; Stroke; Survival Rate; Thiophenes; Ventricular Remodeling | 2001 |
[Antihypertensive drug. Dual action lowers blood pressure more effectively].
Topics: Acrylates; Animals; Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Imidazoles; Thiophenes; Treatment Outcome | 2001 |
Effects of eprosartan versus hydrochlorothiazide on markers of vascular oxidation and inflammation and blood pressure (renin-angiotensin system antagonists, oxidation, and inflammation).
Topics: Acrylates; Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Chemokine CCL2; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Inflammation; Lipoproteins, LDL; Male; Middle Aged; Muscle, Smooth, Vascular; Oxidation-Reduction; Receptors, Angiotensin; Renin-Angiotensin System; Thiophenes; Treatment Outcome; Vascular Cell Adhesion Molecule-1 | 2002 |
Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension.
Topics: Animals; Carbazoles; Desoxycorticosterone; Dose-Response Relationship, Drug; Fluorobenzenes; Hypertension; In Vitro Techniques; Indoles; Ketanserin; Male; Mesenteric Arteries; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Signal Transduction; Sumatriptan; Thiophenes; Vascular Resistance; Vasoconstriction | 2002 |
[Significance of pharmacological blockade of angiotensin II type I receptors for correction of abnormal 24-hour blood pressure profile depending on its variability in patients with arterial hypertension stage II].
Topics: Acrylates; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Blood Pressure; Circadian Rhythm; Humans; Hypertension; Imidazoles; Male; Receptor, Angiotensin, Type 1; Thiophenes | 2002 |
The angiotensin type 1 receptor antagonist, eprosartan, attenuates the progression of renal disease in spontaneously hypertensive stroke-prone rats with accelerated hypertension.
Topics: Acrylates; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Blotting, Western; Body Weight; Dietary Fats; Disease Progression; Extracellular Matrix; Fibrinolysin; Gene Expression Regulation; Heart Rate; Hypertension; Imidazoles; Kidney Diseases; Male; Organ Size; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Serine Proteinase Inhibitors; Sodium Chloride, Dietary; Stroke; Thiophenes; Thrombosis | 2002 |
[Eprosartan mesylate in controlling of blood pressure in patients with ischemic stroke].
Topics: Aged; Antihypertensive Agents; Brain; Brain Ischemia; Cerebrovascular Circulation; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Thiophenes | 2002 |
A potentially antianginal benzo [b]thiophene with an amiodarone-like haemodynamic profile.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Animals; Benzofurans; Blood Pressure; Cardiac Output; Coronary Circulation; Depression, Chemical; Dogs; Electrocardiography; Epinephrine; Female; Heart Rate; Hemodynamics; Hypertension; Isoproterenol; Male; Oxygen Consumption; Propylamines; Tachycardia; Thiophenes; Vascular Resistance | 1975 |
Ticrynafen (Selacryn).
Topics: Diuretics; Drug Interactions; Glycolates; Humans; Hypertension; Phenoxyacetates; Thiophenes; Uricosuric Agents | 1979 |
Tiamenidine, a centrally acting antihypertensive drug in essential hypertension [proceedings].
Topics: Adult; Antihypertensive Agents; Humans; Hypertension; Imidazoles; Male; Middle Aged; Thiophenes | 1979 |
[Action of tienilic acid, a diuretic modifying the tubular system of the excretion of organic acids (author's transl)].
Topics: Adult; Diuretics; Drug Evaluation; Female; Glycolates; Humans; Hypertension; Male; Middle Aged; Penicillins; Phenolsulfonphthalein; Phenoxyacetates; Thiophenes; Uric Acid; Uricosuric Agents | 1978 |
[Acute kidney failure during the administration of an hypouricemic diuretic, tienilic acid].
Topics: Acute Kidney Injury; Diuretics; Glycolates; Humans; Hypertension; Male; Middle Aged; Phenoxyacetates; Thiophenes; Uric Acid | 1978 |
[Thienylic acid, a new drug with saluretic and uricosuric activity. Preliminary data].
Topics: Adult; Aged; Diuretics; Drug Evaluation; Female; Glycolates; Humans; Hypertension; Male; Middle Aged; Phenoxyacetates; Thiophenes; Uric Acid; Uricosuric Agents; Water-Electrolyte Balance | 1978 |
Synthesis and antihypertensive activity of some thienylethanolamines.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Ethanolamines; Hypertension; Lipid Metabolism; Male; Mice; Myocardium; Norepinephrine; Rats; Thiophenes | 1976 |
Antagonism of debrisoquine sulfate by pizotifen (Sandomigran)
Topics: Adult; Debrisoquin; Humans; Hypertension; Isoquinolines; Male; Pizotyline; Thiophenes | 1976 |
Adrenaline-forming enzyme in brainstem: elevation in genetic and experimental hypertension.
Topics: Blood Pressure; Brain Stem; Desoxycorticosterone; Hypertension; Phenylethanolamine N-Methyltransferase; Pyridines; Thiophenes | 1976 |
[Tertatolol--characteristics of the drug].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Animals; Antihypertensive Agents; Diuresis; Diuretics; Dogs; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Middle Aged; Models, Biological; Propanolamines; Rats; Renal Circulation; Thiophenes; Time Factors | 1992 |
Antihypertensive activity of the non-peptide angiotensin II receptor antagonist, SK&F 108566, in rats and dogs.
Topics: Acrylates; Angiotensin I; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Dogs; Hemodynamics; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred Strains; Tetrazoles; Thiophenes | 1992 |
[Renal effects of intravenous tertatolol in essential arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Male; Middle Aged; Natriuresis; Propanolamines; Renal Circulation; Thiophenes; Vascular Resistance | 1990 |
Improvement of diastolic function after reversal of left ventricular hypertrophy induced by long-term antihypertensive treatment with tertatolol.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Cardiomegaly; Echocardiography; Heart Rate; Humans; Hypertension; Myocardial Contraction; Propanolamines; Radionuclide Angiography; Stroke Volume; Thiophenes; Time Factors | 1989 |
Beta-blockade and renal function in hypertension. Symposium.
Topics: Adrenergic beta-Antagonists; Animals; Humans; Hypertension; Kidney; Propanolamines; Thiophenes | 1989 |
Antihypertensive action of beta-adrenoceptor blocking drugs. The role of intrarenal mechanisms.
Topics: Adrenergic beta-Antagonists; Humans; Hypertension; Hypertension, Renovascular; Kidney; Propanolamines; Propranolol; Renal Circulation; Thiophenes; Vasodilation | 1989 |
Effects of long-term antihypertensive treatment with tertatolol on diastolic function in hypertensive patients with and without left ventricular hypertrophy.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Cardiomegaly; Diastole; Echocardiography, Doppler; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Myocardial Contraction; Propanolamines; Thiophenes; Time Factors | 1989 |
Thiophene systems. 9. Thienopyrimidinedione derivatives as potential antihypertensive agents.
Topics: Animals; Blood Pressure; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Hypertension; Kinetics; Phenylephrine; Prazosin; Pyrimidines; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha; Structure-Activity Relationship; Thiophenes | 1988 |
6,7-Dihydro-5-[[(cis-2-hydroxy-trans-3-phenoxycyclopentyl)amino] methyl]-2-methylbenzo[b]thiophen-4(5H)-one: a novel alpha 1-adrenergic receptor antagonist and renal vasodilator.
Topics: Adrenergic alpha-Antagonists; Animals; Chemical Phenomena; Chemistry; Dogs; Hypertension; Male; Natriuresis; Prazosin; Rabbits; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha; Renal Circulation; Stereoisomerism; Thiophenes; Vasodilation | 1985 |
Recent advances in beta blockade. Therapeutic implications in hypertension. Proceedings of the First International Symposium on Tertatolol, 15th June, 1985, Milano, Italy.
Topics: Adrenergic beta-Antagonists; Animals; Cardiovascular System; Humans; Hypertension; Kidney; Propanolamines; Thiophenes | 1986 |
Tertatolol does not affect biochemical markers of atherosclerosis in normo- and hyperlipidemic hypertensive patients.
Topics: Adrenergic beta-Antagonists; Arteriosclerosis; Blood Pressure; Female; Heart Rate; Humans; Hyperlipidemias; Hypertension; Lipids; Male; Middle Aged; Propanolamines; Thiophenes | 1986 |
Long-term experience with tertatolol in hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Creatinine; Female; Heart Rate; Humans; Hypertension; Kidney; Lipids; Male; Middle Aged; Propanolamines; Thiophenes | 1986 |
Role of baroreflex activation in the regional hemodynamic effects of the beta-blockers tertatolol and propranolol in conscious spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Denervation; Hemodynamics; Hypertension; Male; Pressoreceptors; Propanolamines; Rats; Rats, Inbred SHR; Reflex; Renal Circulation; Thiophenes; Vasoconstriction | 1986 |
Study of prejunctional beta-adrenoceptors in kidneys of normotensive and hypertensive rats using the new beta-adrenoceptor blocking drug tertatolol.
Topics: Adrenergic beta-Antagonists; Animals; Hypertension; In Vitro Techniques; Isoproterenol; Kidney; Male; Norepinephrine; Propanolamines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, beta; Thiophenes | 1986 |
Tertatolol preserves renal perfusion in patients with arterial hypertension after head injury.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Craniocerebral Trauma; Female; Hemodynamics; Humans; Hypertension; Kidney; Male; Middle Aged; Perfusion; Propanolamines; Propranolol; Renal Circulation; Thiophenes | 1986 |
Renal hemodynamic effects of tertatolol in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Kidney; Male; Middle Aged; Propanolamines; Propranolol; Renal Circulation; Thiophenes | 1986 |
Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Kidney; Male; Metoclopramide; Middle Aged; Propanolamines; Renal Circulation; Renin; Thiophenes | 1986 |
Effects of tertatolol in hypertensive patients with chronic renal failure.
Topics: Adrenergic beta-Antagonists; Adult; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Propanolamines; Renal Circulation; Renin; Thiophenes | 1986 |
Choosing the right dose for beta-blocker treatment of hypertension: experience with tertatolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Hypertension; Middle Aged; Propanolamines; Thiophenes | 1986 |
Reversal of left ventricular hypertrophy following treatment with beta-blockers: experience with tertatolol.
Topics: Adrenergic beta-Antagonists; Animals; Cardiomegaly; Echocardiography; Humans; Hypertension; Middle Aged; Propanolamines; Thiophenes | 1986 |
[Effects of tertatolol on atherogenicity indices in normo- or dis-lipemic hypertensive patients].
Topics: Adrenergic beta-Antagonists; Female; Humans; Hyperlipidemias; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Propanolamines; Thiophenes; Triglycerides | 1987 |
Electrophysiologic and hemodynamic effects of chronic oral therapy with the alpha 2-agonists clonidine and tiamenidine in hypertensive volunteers.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Adult; Aged; Antihypertensive Agents; Clonidine; Heart Conduction System; Hemodynamics; Humans; Hypertension; Middle Aged; Refractory Period, Electrophysiological; Thiophenes | 1988 |
Tiamenidine (Hoe 440), a new antihypertensive substance.
Topics: Anesthetics, Local; Animals; Antihypertensive Agents; Cats; Cattle; Colon; Dogs; Guinea Pigs; Heart; Hemodynamics; Hypertension; Imidazoles; In Vitro Techniques; Papillary Muscles; Rabbits; Rats; Sympathomimetics; Thiophenes | 1974 |
[Pharmacologic profile of a new non-competitive antiadrenergic agent with an anti-angina potential--a derivative of amiodarone].
Topics: Angina Pectoris; Animals; Anti-Arrhythmia Agents; Benzoates; Benzofurans; Blood Flow Velocity; Blood Pressure; Cardiac Output; Dogs; Ethylamines; Heart Rate; Hypertension; Iodobenzoates; Oxygen Consumption; Propylamines; Tachycardia; Thiophenes; Time Factors | 1973 |